1581 related articles for article (PubMed ID: 19326433)
21. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
[TBL] [Abstract][Full Text] [Related]
22. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.
Blandini F; Levandis G; Bazzini E; Nappi G; Armentero MT
Eur J Neurosci; 2007 Jan; 25(2):397-405. PubMed ID: 17284180
[TBL] [Abstract][Full Text] [Related]
23. Divergent regulatory mechanisms governing BDNF mRNA expression in cerebral cortex and substantia nigra in response to striatal target ablation.
Rite I; Machado A; Cano J; Venero JL
Exp Neurol; 2005 Mar; 192(1):142-55. PubMed ID: 15698628
[TBL] [Abstract][Full Text] [Related]
24. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
Matsuura K; Makino H; Ogawa N
Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
[TBL] [Abstract][Full Text] [Related]
25. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
26. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
[TBL] [Abstract][Full Text] [Related]
27. NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats.
El Arfani A; Bentea E; Aourz N; Ampe B; De Deurwaerdère P; Van Eeckhaut A; Massie A; Sarre S; Smolders I; Michotte Y
Neuropharmacology; 2014 Oct; 85():198-205. PubMed ID: 24863042
[TBL] [Abstract][Full Text] [Related]
28. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
[TBL] [Abstract][Full Text] [Related]
29. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
McPherson RJ; Marshall JF
Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
[TBL] [Abstract][Full Text] [Related]
30. Effects of donor age and brain-derived neurotrophic factor on the survival of dopaminergic neurons and axonal growth in postnatal rat nigrostriatal cocultures.
Ostergaard K; Jones SA; Hyman C; Zimmer J
Exp Neurol; 1996 Dec; 142(2):340-50. PubMed ID: 8934565
[TBL] [Abstract][Full Text] [Related]
31. Counteraction by repetitive daily exposure to static magnetism against sustained blockade of N-methyl-D-aspartate receptor channels in cultured rat hippocampal neurons.
Hirai T; Taniura H; Goto Y; Tamaki K; Oikawa H; Kambe Y; Ogura M; Ohno Y; Takarada T; Yoneda Y
J Neurosci Res; 2005 May; 80(4):491-500. PubMed ID: 15846781
[TBL] [Abstract][Full Text] [Related]
32. Intrastriatal infusions of brain-derived neurotrophic factor: retrograde transport and colocalization with dopamine containing substantia nigra neurons in rat.
Mufson EJ; Kroin JS; Sobreviela T; Burke MA; Kordower JH; Penn RD; Miller JA
Exp Neurol; 1994 Sep; 129(1):15-26. PubMed ID: 7523178
[TBL] [Abstract][Full Text] [Related]
33. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
[TBL] [Abstract][Full Text] [Related]
35. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
[TBL] [Abstract][Full Text] [Related]
36. Loss of D3 receptors in the zitter mutant rat is not reversed by L-dopa treatment.
Joyce JN; Der TC; Renish L; Osredkar T; Hagner D; Reploge M; Sakakibara S; Ueda S
Exp Neurol; 2004 May; 187(1):178-89. PubMed ID: 15081599
[TBL] [Abstract][Full Text] [Related]
37. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
39. Striatal trophic factor activity in aging monkeys with unilateral MPTP-induced parkinsonism.
Collier TJ; Dung Ling Z; Carvey PM; Fletcher-Turner A; Yurek DM; Sladek JR; Kordower JH
Exp Neurol; 2005 Feb; 191 Suppl 1():S60-7. PubMed ID: 15629762
[TBL] [Abstract][Full Text] [Related]
40. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]